Technical Analysis for AMRX - Amneal Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.96% | |
| Down 3 Days in a Row | Weakness | 0.96% | |
| Down 4 Days in a Row | Weakness | 0.96% | |
| Fell Below 20 DMA | Bearish | -0.71% | |
| Fell Below 50 DMA | Bearish | -0.71% | |
| Down 3 Days in a Row | Weakness | -0.71% | |
| Calm After Storm | Range Contraction | -6.56% | |
| Upper Bollinger Band Walk | Strength | -6.56% |
| Alert | Time |
|---|---|
| Possible NR7 | about 18 hours ago |
| Possible Inside Day | about 18 hours ago |
| Down 2 % | about 22 hours ago |
| Down 1% | about 22 hours ago |
| Up 1% | 1 day ago |
Get a Trading Assistant
- Earnings date: 11/08/2024
Amneal Pharmaceuticals, Inc. Description
Amneal Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. It operates in two segments, which include Impax Generics and Impax Specialty Pharma. The Impax Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Impax Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Health Sciences Drugs Pharmaceutical Products Parkinson's Disease Treatment Of Parkinson's Disease Drug Products Headache Migraine Generic Drug Migraine Headache Treatment Of Migraine Migraine Headaches
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.47 |
| 52 Week Low | 3.9912 |
| Average Volume | 637,678 |
| 200-Day Moving Average | 7.00 |
| 50-Day Moving Average | 8.59 |
| 20-Day Moving Average | 8.60 |
| 10-Day Moving Average | 8.75 |
| Average True Range | 0.33 |
| RSI (14) | 45.36 |
| ADX | 18.74 |
| +DI | 17.11 |
| -DI | 37.49 |
| Chandelier Exit (Long, 3 ATRs) | 8.48 |
| Chandelier Exit (Short, 3 ATRs) | 8.51 |
| Upper Bollinger Bands | 9.17 |
| Lower Bollinger Band | 8.03 |
| Percent B (%b) | 0.33 |
| BandWidth | 13.20 |
| MACD Line | 0.02 |
| MACD Signal Line | 0.06 |
| MACD Histogram | -0.0438 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.67 | ||||
| Resistance 3 (R3) | 8.64 | 8.52 | 8.62 | ||
| Resistance 2 (R2) | 8.52 | 8.46 | 8.54 | 8.61 | |
| Resistance 1 (R1) | 8.47 | 8.42 | 8.50 | 8.50 | 8.59 |
| Pivot Point | 8.35 | 8.35 | 8.37 | 8.37 | 8.35 |
| Support 1 (S1) | 8.30 | 8.29 | 8.33 | 8.33 | 8.23 |
| Support 2 (S2) | 8.18 | 8.25 | 8.20 | 8.21 | |
| Support 3 (S3) | 8.13 | 8.18 | 8.20 | ||
| Support 4 (S4) | 8.16 |
